SBRT (stereotactic body radiotherapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SBRT (stereotactic body radiotherapy), covering 2023-09-15 to 2023-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus [Phase 1, Phase 2]